Growth Metrics

Vivos (RDGL) EBIT Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Vivos - - -3,105.00 -65.57%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -65.57%
Sep 30, 2025 37.02%
Jun 30, 2025 -29.19%
Mar 31, 2025 -49.63%
Dec 31, 2024 29.80%
Sep 30, 2024 -22.62%
Jun 30, 2024 42.88%
Mar 31, 2024 -132.42%
Dec 31, 2023 -33.61%
Sep 30, 2023 -148.18%
Jun 30, 2023 -16.11%
Mar 31, 2023 66.78%
Dec 31, 2022 -223.04%
Sep 30, 2022 -42.39%
Jun 30, 2022 57.52%
Mar 31, 2022 -217.96%
Dec 31, 2021 26.02%
Sep 30, 2021 -51.50%
Jun 30, 2021 -1,343.08%
Mar 31, 2021 -95.30%
Dec 31, 2020 9.03%
Sep 30, 2020 78.85%
Jun 30, 2020 25.76%
Mar 31, 2020 46.55%
Dec 31, 2019 81.18%
Sep 30, 2019 -343.52%
Jun 30, 2019 49.40%
Mar 31, 2019 21.45%
Dec 31, 2018 -156.86%
Sep 30, 2018 85.77%
Jun 30, 2018 44.78%
Mar 31, 2018 21.39%
Dec 31, 2017 -611.12%
Sep 30, 2017 -44.32%
Jun 30, 2017 80.76%
Mar 31, 2017 46.56%
Dec 31, 2016 112.08%
Sep 30, 2016 -126.82%
Jun 30, 2016 -872.28%
Mar 31, 2016 -107.57%
Dec 31, 2015 -183.28%
Sep 30, 2015 40.44%
Jun 30, 2015 37.78%
Mar 31, 2015 39.74%
Dec 31, 2014 6.74%
Sep 30, 2014 -0.80%
Jun 30, 2014 55.03%
Mar 31, 2014 63.51%
Dec 31, 2013 73.02%
Sep 30, 2013 78.53%
Jun 30, 2013 48.09%
Mar 31, 2013 -48.20%
Dec 31, 2012 -103.91%
Sep 30, 2012 -334.54%
Jun 30, 2012 -298.77%
Mar 31, 2012 -40.66%
Dec 31, 2011 42.11%
Sep 30, 2011 45.44%
Jun 30, 2011 -32.91%